AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact News To Know: PATH and Jhpiego just launched a call for Expression of Interest (EOI) to identify potential industry partners that can contribute to improving access to life-saving medicines in low- and middle-income countries to prevent and treat postpartum hemorrhage. Manufacturers of misoprostol tablets and tranexamic acid injectables are encouraged to apply! Did you know? Postpartum hemorrhage
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
Jhpiego promotes vaccination efforts across three continents. JHU Hosts a Real-Time Map of COVID-19’s Global Spread We are a proven leader in training vaccinators, community health workers and others supporting vaccination efforts and ensuring quality at vaccination sites to promote vaccine confidence. That’s why our teams are at the forefront of vaccine planning, introduction and scale-up
